Alyse Thompson-Richards

The rescheduling follows a 2025 executive order from President Donald Trump, which called on the U.S. Attorney General to “take all necessary steps to complete the rulemaking process related to rescheduling marijuana.”

The order follows a May 2024 proposed rule from the U.S. Drug Enforcement Administration, which received 43,000 public comments and is awaiting an administrative hearing.

The state adopted medical cannabis in 2016, with sales beginning in early 2019. Voters approved adult-use cannabis last November after an effort spearheaded by The Coalition to Regulate Marijuana Like Alcohol got the initiative on the ballot.

Moving cannabis to Schedule III, where it would exist among ketamine and anabolic steroids, would highlight its accepted medical uses and a lower potential for abuse.

Citing five anonymous sources familiar with the situation, the AP said the DEA’s proposal still requires review by the White House Office of Management and Budget (OMB), as well as a public comment period.

Dry January is drawing to a close, but for makers of cannabis spirits, offering consumers an alternative to alcohol is a priority all year long.

WhistlePig is elevating the non-alcoholic cocktail experience with the addition of non-psychoactive cannabis terpenes to its signature Barrel Aged Maple Old Fashioned recipe.

Part of KANHA’s functional product line, Marionberry-Plum Sleep gummies feature a mix of CBN, CBD, THC and terpenes.

Cannabis Products Insider recently spoke to Jake Hill, co-founder and CEO of Hill Beverage Co., about his cannabis experience, his partnership with Snoop Dogg and what’s next for the company.

Cameron Clarke, Sunderstorm co-founder and CEO, said expanding to Thailand aligns with KANHA's brand story, which aims to break away from stigma and spotlight cannabis’ wellness benefits.